Filing Flows › Prestige Consumer Healthcare (PBH) › Q1 FY27 › vs Q1 FY26
Prestige Consumer Healthcare (PBH) Q1 FY27 vs Q1 FY26 (year over year)
Prestige Consumer Healthcare's revenue rose $16.2M (+6%) from $250M in Q1 FY26 to $266M in Q1 FY27. The biggest changes: Wellness, Sleep & Other +$9.2M (+180%); Gastrointestinal +$4.4M (+8%); Dermatologicals +$3.1M (+10%). Gross margin 51.3% against 56.2% (-5.0 pts).
Prestige Consumer Healthcare, Q1 FY27: revenue $266M (+6% year over year), operating margin 19.8%, net earnings $29.2M, operating cash flow $70.8M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 51.3% | 56.2% | -5.0 pts |
| Operating margin | 19.8% | 28.8% | -9.0 pts |
| Net margin | 11.0% | 19.0% | -8.0 pts |
| Free cash flow margin | 25.2% | 31.3% | -6.1 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Gastrointestinal | $62.2M | $57.8M | $4.4M | +8% |
| Women's Health | $52.5M | $54.6M | −$2.0M | -4% |
| Dermatologicals | $33.2M | $30.1M | $3.1M | +10% |
| Eye & Ear Care | $33.0M | $32.3M | $670K | +2% |
| Pain Relief | $26.8M | $28.9M | −$2.1M | -7% |
| Oral Care | $22.4M | $21.7M | $656K | +3% |
| Cough, Cold & Allergy | $21.3M | $19.0M | $2.3M | +12% |
| Wellness, Sleep & Other | $14.3M | $5.1M | $9.2M | +180% |
| Revenue | $266M | $250M | $16.2M | +6% |
| Gross profit | $136M | $140M | −$4.1M | -3% |
| Cost of revenue | $130M | $109M | $20.3M | +19% |
| Operating profit | $52.5M | $71.8M | −$19.2M | -27% |
| Operating expenses | $83.7M | $68.6M | $15.1M | +22% |
| Pre-tax earnings | $38.5M | $61.8M | −$23.2M | -38% |
| Other expense, net | $14.0M | $10.0M | $4.0M | +40% |
| Sales & marketing | $34.7M | $34.9M | −$269K | -0.8% |
| General & admin | $43.3M | $28.5M | $14.8M | +52% |
| Other operating costs | $5.7M | $5.2M | $515K | +10% |
| Net earnings | $29.2M | $47.5M | −$18.3M | -39% |
| Income tax | $9.4M | $14.3M | −$4.9M | -35% |
| Depreciation & amortization | $8.8M | $7.7M | $1.1M | +14% |
| Share-based compensation | $4.0M | $3.7M | $312K | +8% |
| Working capital & other | $28.9M | $20.2M | $8.7M | +43% |
| Operating cash flow | $70.8M | $79.0M | −$8.2M | -10% |
| Free cash flow (OCF − capex) | $67.1M | $78.2M | −$11.1M | -14% |
| Capital expenditures | $3.7M | $838K | $2.9M | +342% |
Questions
How much did Prestige Consumer Healthcare's revenue grow year over year in Q1 FY27?
Prestige Consumer Healthcare's revenue rose $16.2M (+6%) from $250M in Q1 FY26 to $266M in Q1 FY27.
What drove Prestige Consumer Healthcare's revenue change in Q1 FY27?
Wellness, Sleep & Other +$9.2M (+180%); Gastrointestinal +$4.4M (+8%); Dermatologicals +$3.1M (+10%).